Nexera Technologies (NEXR) director reports 5,540 shares and RSU grants
Filing Impact
Filing Sentiment
Form Type
3/A
Rhea-AI Filing Summary
Nexera Technologies Ltd director Revach Moshe reports beneficial ownership of 5,540 ordinary shares. This figure includes restricted share units (RSUs) with different grant and vesting schedules. As of March 18, 2026, 242 RSUs were granted on September 16, 2025, vesting quarterly at 12.5% from December 10, 2025, with 60 vested and 182 unvested. Another 1,013 RSUs were granted on January 1, 2026, also vesting quarterly at 12.5% from that date, all unvested as of March 18, 2026. A further 2,143 RSUs granted on February 1, 2026 had fully vested on that grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Revach Moshe
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Ordinary shares — 5,540 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Ordinary shares owned: 5,540 shares
RSUs granted Sep 16, 2025: 242 RSUs
Unvested RSUs from Sep 16, 2025 grant: 182 RSUs
+3 more
6 metrics
Ordinary shares owned
5,540 shares
Beneficial ownership as of March 18, 2026
RSUs granted Sep 16, 2025
242 RSUs
12.5% quarterly vesting from December 10, 2025
Unvested RSUs from Sep 16, 2025 grant
182 RSUs
Unvested as of March 18, 2026
RSUs granted Jan 1, 2026
1,013 RSUs
12.5% quarterly vesting from January 1, 2026; all unvested as of March 18, 2026
RSUs granted Feb 1, 2026
2,143 RSUs
Fully vested on February 1, 2026
RSU vesting rate
12.5% per quarter
Applies to 2025 and January 2026 RSU grants
Key Terms
restricted share units ("RSUs"), vesting commencement date, equal quarterly installments, unvested, +1 more
5 terms
vesting commencement date financial
"and the vesting commencement date is September 10, 2025"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
equal quarterly installments financial
"which vest in equal quarterly installments of 12.5% beginning on December 10, 2025"
unvested financial
"of which 60 RSUs have vested and 182 remain unvested as of March 18, 2026"
granted financial
"1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments"
FAQ
What does Nexera Technologies (NEXR) director Revach Moshe report in this Form 3/A?
Revach Moshe reports beneficial ownership of 5,540 ordinary shares of Nexera Technologies Ltd. This total includes several blocks of restricted share units (RSUs) with different grant dates and vesting schedules as of March 18, 2026.
How many Nexera Technologies (NEXR) RSUs were granted to Revach Moshe on September 16, 2025?
Revach Moshe received 242 RSUs on September 16, 2025, with vesting commencing September 10, 2025. These RSUs vest in 12.5% quarterly installments starting December 10, 2025, with 60 vested and 182 unvested as of March 18, 2026.
What are the details of the January 1, 2026 RSU grant to Revach Moshe at Nexera Technologies (NEXR)?
On January 1, 2026, Revach Moshe was granted 1,013 RSUs. These RSUs vest in equal quarterly installments of 12.5% beginning January 1, 2026, and all remained unvested as of March 18, 2026, according to the disclosure.
Which RSUs for Nexera Technologies (NEXR) had fully vested for Revach Moshe by March 18, 2026?
A grant of 2,143 RSUs to Revach Moshe on February 1, 2026 had fully vested on that same date. Additional RSUs from earlier grants had partially vested, while others remained unvested as described in the filing footnote.
Does the Nexera Technologies (NEXR) Form 3/A show any buy or sell transactions by Revach Moshe?
The Form 3/A reflects reported holdings rather than explicit buy or sell transactions. It lists 5,540 ordinary shares beneficially owned and breaks down RSU grants and vesting status, without specifying open-market purchases or sales in this disclosure.